OR WAIT null SECS
November 15, 2023
Parties will provide processing and packaging machinery services.
November 14, 2023
Stem Cell Reports takes a look at DTC online advertising claims that these are ‘immune boosters.’
Bayer said it will explore access options for patients with follicular lymphoma currently receiving Aliqopa who have experienced a favorable response to treatment.
November 10, 2023
Blue Fin Group exec speaks on his upcoming feature.
Financial commitment further strengthens IntegriChain’s platform as a source for pharma manufacturers' commercialization and market access goals.
November 09, 2023
Blue Fin Group executive highlights how leaders can plan for immediate profitable lifecycles and beyond.
SVP and Managing Director for Blue Fin Group offers a synopsis of the conference opener.
Session explains how to use this information to help bolster market intelligence, market access, and affordability strategies.
Conference presentation explores groundbreaking topics impacting the pharma industry.
November 08, 2023
Session explores how on-market products have done, and what to expect from new biosimilars.